Evaluation of large language models for carbohydrate counting in type 1 diabetes mellitus: a comparative study with patient estimations


Soyer A. K., Akarsu G. Ç., Yelli B. D., Tural Balsak B. Ö., ÖZDEMİR D., TOPALOĞLU O., ...Daha Fazla

Diabetes Research and Clinical Practice, cilt.236, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 236
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.diabres.2026.113279
  • Dergi Adı: Diabetes Research and Clinical Practice
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, Index Islamicus, MEDLINE
  • Anahtar Kelimeler: Artificial intelligence in diabetes, Carbohydrate counting, Type 1 diabetes mellitus
  • Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet

Özet

Aims: To evaluate large language models (LLMs) accuracy in carbohydrate (CHO) counting (CC) and compare their performance with estimations by patients with type-1 diabetes mellitus (T1DM). Methods: This cross-sectional study included 14 adults with T1DM with advanced CC training and > 70% accuracy on the AdultCarbQuiz. Eighteen main meals and four snacks were prepared by dietitians using standardized descriptions and two-angle photographs. Dietitian-determined values served as the reference. CHO estimations by patients and LLMs (ChatGPT-5.2, Gemini-3 Pro, and Claude Sonnet-4.5) were compared. LLM performance was evaluated in two-stages: image-only (stage-1) and image-plus-detailed-description (stage-2) inputs. Performance was assessed using mean absolute error (MAE), mean absolute percentage error (MAPE), counting accuracy (CA; ≤10 g), Wilcoxon signed-rank test, and Bland–Altman analysis. Results: Patients showed MAE 8.31 g, MAPE 13.82%, and CA 73.74%. In Stage-1, Gemini had the lowest MAE (6.55 g), and MAPE (12.54%), while Claude achieved the highest CA (81.8%). In Stage-2, Gemini outperformed patients (p < 0.001) with MAE 2.14 g, MAPE 3.21%, CA 100%, and mean bias − 1.05 g. Other model–stage combinations showed performance comparable to patients. Conclusion: LLMs, particularly Gemini-3 Pro, may support CC when detailed inputs are provided; however, findings should be interpreted cautiously given the small, highly selected sample.